MedTrace Logo

The Effect of Adenomoyosis on Pregnancy Outcomes

NCT04894292 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-05-25

No results posted yet for this study

Summary

Adenomyosis can be defined as the settling of endometrial gland cells in the myometrium and deformity in the uterus and the prevalence of adenomyosis is according to the patient population and countries around 20%. There are recent publications reporting that this rate increases up to 50% in women dealing with infertility. In adenomyosis, where uterine morphology is affected, it is not thought that the uterus, which is expected to provide many morphological adaptations during pregnancy, will not be affected. Therefore, in this prospective study, it was planned to investigate the effects of adenomyosis during pregnancy.

For this study the presence of adenomyosis will be questioned by using ultrasonographic morphological uterine limitation (MUSA) in women who apply to the outpatient clinic with suspicion of pregnancy and undergo transvaginal ultrasonography for the diagnosis of pregnancy before sixth gestational week.

Patients will be divided into two groups according to the presence of adenomyosis and pregnancy complications such as preterm labor, premature rupture of membranes, cesarean section rates, preeclampsia, fetal malpresentation and preeclampsia will be compared between the groups.

Conditions

  • Adenomyosis
  • Pregnancy Complications

Interventions

OTHER

Non intervention

During the study there is no extra intervention planned for the participants.

Sponsors & Collaborators

  • Tepecik Training and Research Hospital

    lead OTHER

Principal Investigators

  • Ahkam Göksel Kanmaz, Assoc. Prof. · Tepecik Education and Research Hospital

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-20
Primary Completion
2022-08-31
Completion
2022-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04894292 on ClinicalTrials.gov